C&EN article by Shi En Kim
November 13, 2022 | A version of this story appeared in Volume 100, Issue 40
IN BRIEF:
The lack of gravity in space opens up unique opportunities for drug design and development. With the influx of commercial entities providing access to low-Earth orbit, both the discovery and manufacture of drugs in space may one day become practical, affordable—and, perhaps, commonplace.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.
More information: Pavláth Attila szimpózium meghívó_EnglishDownload Photos: https://www.flickr.com/photos/mtasajto/albums/72177720299384474
We are pleased to inform you that InnoStudio will attend the event and give a talk about "Miniaturized and modular flow chemical reactor for space applications" on April 7, at 16.30 PM. Preliminary agenda now available at:...
Organized by the Japan Manned Space Systems Corporation and InnoStudio, the first ever webinar series dedicated to pharmaceutical research and drug discovery in space, with both scientific and commercial aspects, is now bringing you the newest results and...
The recent and successful study of InnoStudio and CycloLab for COVID-19 drug research in space has been gaining attention and receiving positive feedback worldwide. The Roscosmos State Corporation for Space Activities found our idea and experiment valuable enough to...
For the past 20 years, astronauts have been performing experiments on the International Space Station. Science in low Earth orbit is not only hugely important in preparation for continued space exploration, the research also benefits life on Earth. We’ve seen...
The COVID-19 epidemic posed new and pressing challenges for pharmaceutical researchers. Gilead Sciences' Veklury was the first drug to treat COVID-19 infection that was provisionally approved in more than 50 countries. It is also the first product to receive a full,...
